Deal Details

Accolade Completes $253.6 Million Initial Public Offering

Healthcare

Accolade initial public offering

Summary

Accolade, Inc. (“Accolade” or the “Company”) (NASDAQ-GS:ACCD) recently completed an initial public offering of 11,526,134 shares of its common stock at a public offering price of $22.00 per share for gross proceeds of $253.6 million, which includes the exercise in full by the underwriters of their option to purchase an additional 1,503,408 shares of common stock. The Company expects to use the net proceeds from this offering for general corporate purposes, including working capital, operating expenses, and capital expenditures, and may include the repayment of indebtedness. It may also use a portion of the net proceeds for acquisitions or strategic investments in complementary businesses, products, services, or technologies.

Baird served as a co-manager on this offering.

About

Accolade provides personalized, technology-enabled solutions that help people better understand, navigate, and utilize the healthcare system and their workplace benefits. The Company's customers are primarily employers that deploy Accolade as the single place for their employees and their families to turn to for their health, healthcare, and benefits. Accolade's innovative platform combines open, cloud-based intelligent technology with multimodal support from a team of empathetic and knowledgeable Accolade Health Assistants and clinicians. The platform dramatically improves member experience, encourages better health outcomes, and lowers costs for both members and customers. Accolade is co-headquartered in Seattle, Washington and Plymouth Meeting, Pennsylvania.